Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bausch Health
Pharma
Activist investor Icahn takes 34% interest in Bausch Health
The company discovered the size of activist investor Carl Icahn's economic interest after initiating a "poison pill" plan to ward off unwanted takeovers.
Zoey Becker
Apr 22, 2025 6:39pm
After M&A rumors, Bausch + Lomb confirms it's exploring a sale
Dec 12, 2024 11:26am
Amid turnaround, Emergent BioSolutions names Joseph Papa its CEO
Feb 21, 2024 10:56am
Salix co-creates awareness day for opioid-induced constipation
Dec 5, 2023 8:00am
Bausch notches win in Xifaxan case against Alvogen
Nov 3, 2023 11:17am
Bausch starts first TV campaign for seasonal depression drug
Oct 27, 2023 9:20am
